The monoclonal antibody Rituximab (Anti-CD20) is a chimeric molecule, with both mouse and human components. Given the function of Rituximab, why do you think it was given a human heavy chain constant region?

Question

Answer

To bring Rituxmab into line with all other therapeutic monoclonal antibodies for dosage and treatment frequency.

Answer

To prolong the half-life of the antibody in the patients, thereby improving its efficacy.

Answer

To avoid an immune response in the recipients.

Answer

To activate immune functions of the patient.

Crowdly

The monoclonal antibody Rituximab (Anti-CD20) is a chimeric molecule, with both ...

Want instant access to all verified answers on learning.monash.edu?